http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4001251-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4655b70cbfba352025a1d2393b449e77
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D461-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D461-00
filingDate 1975-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1977-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c60cb7d414de5b538f32ab7cf8dddd53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a58cd4d6db30c398f709e386b25bd758
publicationDate 1977-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4001251-A
titleOfInvention Apovincaldehyde
abstract Vincamine and/or its stereoisomers, a known drug, is made from vincaminol and/or its stereoisomers by successive conversion of the latter into apovincaldehyde, apovincamine, and 16-methoxycarbonyl-eburnane, followed by conversion of the last into vincamine either directly by introduction of a 16-hydroxyl group or by hydrolysis, introduction of a 16-hydroxyl group, and re-esterification.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4883876-A
priorityDate 1972-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129440598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226553306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127979515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226848440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419594984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419594981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12336975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129861505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10877271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450926304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136043617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226479225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411314576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56605938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226513188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454468409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID224807760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410522691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID347919746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID201188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453050886

Total number of triples: 56.